TNA
GILD icon

True North Advisors’s Gilead Sciences GILD Stock Holding History

True North Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,565
Closed -$618K – 260
2025
Q3 		$618K Buy
+5,565
New +$633K 0.1% 115
2023
Q4 		– Sell
-6,791
Closed -$509K – 204
2023
Q3 		$509K Sell
6,791
-6,654
-49% -$512K 0.16% 110
2023
Q2 		$1.04M Sell
13,445
-6,667
-33% -$532K 0.29% 65
2023
Q1 		$1.67M Sell
20,112
-1,975
-9% -$164K 0.49% 50
2022
Q4 		$1.9M Buy
22,087
+1,975
+10% +$156K 0.65% 40
2022
Q3 		$1.24M Hold
20,112
– – 0.41% 62
2022
Q2 		$1.24M Sell
20,112
-90
-0.4% -$5.57K 0.39% 67
2022
Q1 		$1.2M Sell
20,202
-39,944
-66% -$2.55M 0.32% 73
2021
Q4 		$4.37M Buy
60,146
+7,604
+14% +$524K 0.74% 27
2021
Q3 		$3.67M Buy
52,542
+25
+0% +$1.76K 0.72% 30
2021
Q2 		$3.62M Hold
52,517
– – 0.75% 26
2021
Q1 		$3.39M Hold
52,517
– – 0.81% 24
2020
Q4 		$3.06M Sell
52,517
-3,013
-5% -$182K 0.79% 32
2020
Q3 		$3.51M Sell
55,530
-79,985
-59% -$5.55M 1.02% 23
2020
Q2 		$10.4M Buy
135,515
+4,443
+3% +$340K 2.51% 11
2020
Q1 		$9.8M Buy
131,072
+27
+0% +$1.87K 3.34% 9
2019
Q4 		$8.52M Buy
+131,045
New +$8.53M 2.4% 12

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

True North Advisors's GILD Position: Q4 2025 in Review

True North Advisors sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 5,565 shares — an estimated $618K sold.

True North Advisors first reported a position in GILD in Q4 2019 and held it in 17 quarters. The position peaked at $10.4M in Q2 2020. 2,220 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • True North Advisors reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • True North Advisors sold 5,565 Gilead Sciences shares in Q4 2025, an estimated $618K.
  • True North Advisors first reported a position in Gilead Sciences in Q4 2019 and held it in 17 quarters.
  • True North Advisors's Gilead Sciences position peaked at $10.4M in Q2 2020.
  • 2,220 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on True North Advisors's 13F filing for Q4 2025, filed 22 Jan 2026.